- call +1-201-465-4211
- email sales@mrinsights.biz
Hormone replacement therapy refers to the treatment of the patients with growth hormone deficiency due to conditions such as dwarfism or women nearing menopause, which requires replacement of hormones in the body whose levels have become low.
Scope of the Report:
This report studies the Hormone Replacement Therapy market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Hormone Replacement Therapy market by product type and applications/end industries.
Hormonal imbalance disorders, with an increase in the geriatric population, is one of the major factors responsible for the growth of this market. The risk of cancer associated with the HRT certainly restricts the growth of this market. The combination HRT increases the risk of breast cancer by nearly 70%, even when used for a short period of time. The Cancer Research UK has shown in past that HRT increases the risk for several types of cancers, including uterus and ovarian cancers. The United States is expected to have the largest market share in the forecast period. Growing geriatric population is one of the primary factors for the growth of the market.
The global Hormone Replacement Therapy market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Hormone Replacement Therapy.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
F. Hoffmann-La Roche
Novartis
Novo Nordisk
Amgen
ANI Pharmaceuticals
Bayer
Eli Lilly
Hisamitsu Pharmaceutical
Ipsen
Merck
Mylan Laboratories
Orion
QuatRx Pharmaceuticals
Teva Pharmaceutical Industries
TherapeuticsMD
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Estrogen Replacement Therapy
Growth Hormone Replacement Therapy
Market Segment by Applications, can be divided into
Menopause
Hypothyroidism
Male Hypogonadism
Growth Hormone Deficiency
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Hormone Replacement Therapy Market Overview
1.1 Product Overview and Scope of Hormone Replacement Therapy
1.2 Classification of Hormone Replacement Therapy by Types
1.2.1 Global Hormone Replacement Therapy Revenue Comparison by Types (2017-2023)
1.2.2 Global Hormone Replacement Therapy Revenue Market Share by Types in 2017
1.2.3 Estrogen Replacement Therapy
1.2.4 Growth Hormone Replacement Therapy
1.3 Global Hormone Replacement Therapy Market by Application
1.3.1 Global Hormone Replacement Therapy Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Menopause
1.3.3 Hypothyroidism
1.3.4 Male Hypogonadism
1.3.5 Growth Hormone Deficiency
1.4 Global Hormone Replacement Therapy Market by Regions
1.4.1 Global Hormone Replacement Therapy Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Hormone Replacement Therapy Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Hormone Replacement Therapy Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Hormone Replacement Therapy Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Hormone Replacement Therapy Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Hormone Replacement Therapy Status and Prospect (2013-2023)
1.5 Global Market Size of Hormone Replacement Therapy (2013-2023)
2 Manufacturers Profiles
2.1 F. Hoffmann-La Roche
2.1.1 Business Overview
2.1.2 Hormone Replacement Therapy Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 F. Hoffmann-La Roche Hormone Replacement Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.2 Novartis
2.2.1 Business Overview
2.2.2 Hormone Replacement Therapy Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Novartis Hormone Replacement Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.3 Novo Nordisk
2.3.1 Business Overview
2.3.2 Hormone Replacement Therapy Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Novo Nordisk Hormone Replacement Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.4 Amgen
2.4.1 Business Overview
2.4.2 Hormone Replacement Therapy Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Amgen Hormone Replacement Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.5 ANI Pharmaceuticals
2.5.1 Business Overview
2.5.2 Hormone Replacement Therapy Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 ANI Pharmaceuticals Hormone Replacement Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.6 Bayer
2.6.1 Business Overview
2.6.2 Hormone Replacement Therapy Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Bayer Hormone Replacement Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.7 Eli Lilly
2.7.1 Business Overview
2.7.2 Hormone Replacement Therapy Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Eli Lilly Hormone Replacement Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.8 Hisamitsu Pharmaceutical
2.8.1 Business Overview
2.8.2 Hormone Replacement Therapy Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Hisamitsu Pharmaceutical Hormone Replacement Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.9 Ipsen
2.9.1 Business Overview
2.9.2 Hormone Replacement Therapy Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Ipsen Hormone Replacement Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.10 Merck
2.10.1 Business Overview
2.10.2 Hormone Replacement Therapy Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Merck Hormone Replacement Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.11 Mylan Laboratories
2.11.1 Business Overview
2.11.2 Hormone Replacement Therapy Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Mylan Laboratories Hormone Replacement Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.12 Orion
2.12.1 Business Overview
2.12.2 Hormone Replacement Therapy Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Orion Hormone Replacement Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.13 QuatRx Pharmaceuticals
2.13.1 Business Overview
2.13.2 Hormone Replacement Therapy Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 QuatRx Pharmaceuticals Hormone Replacement Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.14 Teva Pharmaceutical Industries
2.14.1 Business Overview
2.14.2 Hormone Replacement Therapy Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Teva Pharmaceutical Industries Hormone Replacement Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.15 TherapeuticsMD
2.15.1 Business Overview
2.15.2 Hormone Replacement Therapy Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 TherapeuticsMD Hormone Replacement Therapy Revenue, Gross Margin and Market Share (2016-2017)
3 Global Hormone Replacement Therapy Market Competition, by Players
3.1 Global Hormone Replacement Therapy Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Hormone Replacement Therapy Players Market Share
3.2.2 Top 10 Hormone Replacement Therapy Players Market Share
3.3 Market Competition Trend
4 Global Hormone Replacement Therapy Market Size by Regions
4.1 Global Hormone Replacement Therapy Revenue and Market Share by Regions
4.2 North America Hormone Replacement Therapy Revenue and Growth Rate (2013-2018)
4.3 Europe Hormone Replacement Therapy Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Hormone Replacement Therapy Revenue and Growth Rate (2013-2018)
4.5 South America Hormone Replacement Therapy Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Hormone Replacement Therapy Revenue and Growth Rate (2013-2018)
5 North America Hormone Replacement Therapy Revenue by Countries
5.1 North America Hormone Replacement Therapy Revenue by Countries (2013-2018)
5.2 USA Hormone Replacement Therapy Revenue and Growth Rate (2013-2018)
5.3 Canada Hormone Replacement Therapy Revenue and Growth Rate (2013-2018)
5.4 Mexico Hormone Replacement Therapy Revenue and Growth Rate (2013-2018)
6 Europe Hormone Replacement Therapy Revenue by Countries
6.1 Europe Hormone Replacement Therapy Revenue by Countries (2013-2018)
6.2 Germany Hormone Replacement Therapy Revenue and Growth Rate (2013-2018)
6.3 UK Hormone Replacement Therapy Revenue and Growth Rate (2013-2018)
6.4 France Hormone Replacement Therapy Revenue and Growth Rate (2013-2018)
6.5 Russia Hormone Replacement Therapy Revenue and Growth Rate (2013-2018)
6.6 Italy Hormone Replacement Therapy Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Hormone Replacement Therapy Revenue by Countries
7.1 Asia-Pacific Hormone Replacement Therapy Revenue by Countries (2013-2018)
7.2 China Hormone Replacement Therapy Revenue and Growth Rate (2013-2018)
7.3 Japan Hormone Replacement Therapy Revenue and Growth Rate (2013-2018)
7.4 Korea Hormone Replacement Therapy Revenue and Growth Rate (2013-2018)
7.5 India Hormone Replacement Therapy Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Hormone Replacement Therapy Revenue and Growth Rate (2013-2018)
8 South America Hormone Replacement Therapy Revenue by Countries
8.1 South America Hormone Replacement Therapy Revenue by Countries (2013-2018)
8.2 Brazil Hormone Replacement Therapy Revenue and Growth Rate (2013-2018)
8.3 Argentina Hormone Replacement Therapy Revenue and Growth Rate (2013-2018)
8.4 Colombia Hormone Replacement Therapy Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Hormone Replacement Therapy by Countries
9.1 Middle East and Africa Hormone Replacement Therapy Revenue by Countries (2013-2018)
9.2 Saudi Arabia Hormone Replacement Therapy Revenue and Growth Rate (2013-2018)
9.3 UAE Hormone Replacement Therapy Revenue and Growth Rate (2013-2018)
9.4 Egypt Hormone Replacement Therapy Revenue and Growth Rate (2013-2018)
9.5 Nigeria Hormone Replacement Therapy Revenue and Growth Rate (2013-2018)
9.6 South Africa Hormone Replacement Therapy Revenue and Growth Rate (2013-2018)
10 Global Hormone Replacement Therapy Market Segment by Type
10.1 Global Hormone Replacement Therapy Revenue and Market Share by Type (2013-2018)
10.2 Global Hormone Replacement Therapy Market Forecast by Type (2018-2023)
10.3 Estrogen Replacement Therapy Revenue Growth Rate (2013-2023)
10.4 Growth Hormone Replacement Therapy Revenue Growth Rate (2013-2023)
11 Global Hormone Replacement Therapy Market Segment by Application
11.1 Global Hormone Replacement Therapy Revenue Market Share by Application (2013-2018)
11.2 Hormone Replacement Therapy Market Forecast by Application (2018-2023)
11.3 Menopause Revenue Growth (2013-2018)
11.4 Hypothyroidism Revenue Growth (2013-2018)
11.5 Male Hypogonadism Revenue Growth (2013-2018)
11.6 Growth Hormone Deficiency Revenue Growth (2013-2018)
12 Global Hormone Replacement Therapy Market Size Forecast (2018-2023)
12.1 Global Hormone Replacement Therapy Market Size Forecast (2018-2023)
12.2 Global Hormone Replacement Therapy Market Forecast by Regions (2018-2023)
12.3 North America Hormone Replacement Therapy Revenue Market Forecast (2018-2023)
12.4 Europe Hormone Replacement Therapy Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Hormone Replacement Therapy Revenue Market Forecast (2018-2023)
12.6 South America Hormone Replacement Therapy Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Hormone Replacement Therapy Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Hormone Replacement Therapy Picture
Table Product Specifications of Hormone Replacement Therapy
Table Global Hormone Replacement Therapy and Revenue (Million USD) Ma
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
